Thu, April 19, 2012
Wed, April 18, 2012
Tue, April 17, 2012
Mon, April 16, 2012
Sun, April 15, 2012
[ Sun, Apr 15th 2012 ] - Market Wire
DaVita Announces CFO Transition
Sat, April 14, 2012
Fri, April 13, 2012
Thu, April 12, 2012
Wed, April 11, 2012
Tue, April 10, 2012
Mon, April 9, 2012
Fri, April 6, 2012
Thu, April 5, 2012
[ Thu, Apr 05th 2012 ] - Market Wire
April 30, 2012
Wed, April 4, 2012
Tue, April 3, 2012
[ Tue, Apr 03rd 2012 ] - Market Wire
EntreMed Appoints Interim CEO
Mon, April 2, 2012

Harwood Feffer LLP Announces Investigation of Optimer Pharmaceuticals, Inc.


//health-fitness.news-articles.net/content/2012/ .. nvestigation-of-optimer-pharmaceuticals-inc.html
Published in Health and Fitness on Wednesday, April 11th 2012 at 9:16 GMT by Market Wire   Print publication without navigation


Harwood Feffer LLP Announces Investigation of Optimer Pharmaceuticals, Inc. -- NEW YORK, April 11, 2012 /PRNewswire/ --

Harwood Feffer LLP Announces Investigation of Optimer Pharmaceuticals, Inc.

[ ]

NEW YORK, April 11, 2012/PRNewswire/ -- Harwood Feffer LLP ([ www.hfesq.com ]) is investigating potential claims against the board of directors of Optimer Pharmaceuticals, Inc. ("Optimer" or the "Company") (NASDAQ: [ OPTR ]), concerning whether the board has breached its fiduciary duties to shareholders.

(Logo: [ http://photos.prnewswire.com/prnh/20120215/MM54604LOGO ] )

On April 9, 2012, Optimer fired its Chairman, CFO, and a vice president due to a failure of corporate governance practices in connection with a Taiwanese affiliate of the Company.  One of the Company's founders, Michael Chang, was terminated after he failed to properly manage record keeping and conflict of interest issues related to a grant of 1.5 million shares he received from the Taiwanese affiliate.  The two terminated officers failed to follow procedures upon learning of the grant.  On this news, shares of Optimer fell nearly 20% over two days to a midday low of $11.91 on April 10, 2012.  Optimer claims to be cooperating with the relevant U.S. authorities as they review the matter.

Our investigation concerns whether the Optimer board of directors has breached its fiduciary duties to shareholders, grossly mismanaged the Company, and/or committed abuses of control in connection with the foregoing.

If you own Optimer shares and wish to discuss this matter with us, or have any questions concerning your rights and interests with regard to this matter, please contact:

cellpadding="0" cellspacing="0" id="convertedTable" style="BORDER-BOTTOM: 1pt; BORDER-LEFT: 1pt; BORDER-COLLAPSE: collapse; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">

Robert I. Harwood, Esq.


Benjamin Sachs-Michaels


Harwood Feffer LLP


488 Madison Avenue


New York, New York 10022


Phone Numbers:

(877) 935-7400


(212) 935-7400

Email:

[ bsachsmichaels@hfesq.com ]

Website:

[ http://www.hfesq.com ]

Harwood Feffer has been representing individual and institutional investors for many years, serving as lead counsel in numerous cases in federal and state courts. Please visit the Harwood Feffer LLP website ([ http://www.hfesq.com ]) for more information about the firm.

Attorney Advertising. © 2011 Harwood Feffer LLP. The law firm responsible for this advertisement is Harwood Feffer LLP ([ www.hfesq.com ]). Prior results do not guarantee or predict a similar outcome with respect to any future matter.

SOURCE Harwood Feffer LLP

[ Back to top ]

RELATED LINKS
[ www.hfesq.com ]


Publication Contributing Sources